I agree that this site is using cookies. You can find further informations here.
X
Van der Aa, Frank
514  results:
OpenAccess-fulltext X
Search for persons X
?
1

Augmenting THerapeutic Effectiveness Through Novel Analytic..:

Petsophonsakul, Ploingarm ; PIRMANI, Ashkan ; DE BROUWER, Edward...
Challenges of Trustable AI and Added-Value on Health, , p. 829 -833.  , 2022
Link: http://hdl.handle.net/19..
 
?
2

Phase I Trial of I-GMIB-Anti-HER2-VHH1, a New Promising Can..:

D'Huyvetter, Matthias ; Vos, Jens De ; Caveliers, Vicky...
boreal:259563.  , 2021
Link: http://hdl.handle.net/20..
 
?
3

Phase I Trial of 131I-GMIB-Anti-HER2-VHH1, a New Promising ..:

D'Huyvetter, Matthias ; Vos, Jens De ; Caveliers, Vicky...
D'Huyvetter , M , Vos , J D , Caveliers , V , Vaneycken , I , Heemskerk , J , Duhoux , F P , Fontaine , C , Vanhoeij , M , Windhorst , A D , Aa , F V D , Hendrikse , N H , Eersels , J L E , Everaert , H , Gykiere , P , Devoogdt , N , Raes , G , Lahoutte , T & Keyaerts , M 2021 , ' Phase I Trial of 131I-GMIB-Anti-HER2-VHH1, a New Promising Candidate for HER2-Targeted Radionuclide Therapy in Breast Cancer Patients ' , Journal of nuclear medicine : official publication, Society of Nuclear Medicine , vol. 62 , no. 8 , pp. 1097-1105 . https://doi.org/10.2967/jnumed.120.255679.  , 2021
Link: https://research.vumc.nl..
 
?
4

Phase I Trial of I-GMIB-Anti-HER2-VHH1, a New Promising Can..:

D'Huyvetter, Matthias ; Vos, Jens De ; Caveliers, Vicky...
boreal:259563.  , 2021
Link: http://hdl.handle.net/20..
 
?
5

Cytokeratin 5 and cytokeratin 20 inversely correlate with t..:

Muilwijk, Tim ; Akand, Murat ; Van der Aa, Frank...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358875/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
6

Cytokeratin 5 and cytokeratin 20 inversely correlate with t..:

Muilwijk, Tim ; Akand, Murat ; Van der Aa, Frank...
boreal:248869.  , 2021
Link: http://hdl.handle.net/20..
 
?
7

Cytokeratin 5 and cytokeratin 20 inversely correlate with t..:

Muilwijk, Tim ; Akand, Murat ; Van der Aa, Frank...
boreal:248869.  , 2021
Link: http://hdl.handle.net/20..
 
?
8

Development of a flowchart reflecting the current attitude ..:

Ghijselings, Lynn ; Hervé, Francois ; Van der Aa, Frank...
boreal:249935.  , 2020
Link: http://hdl.handle.net/20..
 
?
9

Prognostic score predicts overall survival following comple..:

Akand, Murat ; Muilwijk, Tim ; Van Der Aa, Frank...
10.1080/21681805.2020.1716069.  , 2020
Link: https://hdl.handle.net/2..
 
?
10

Preclinical Targeted α- and β(−)-Radionuclide Therapy in HE..:

Puttemans, Janik ; Dekempeneer, Yana ; Eersels, Jos L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226418/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
11

Preclinical Targeted α- and β−-Radionuclide Therapy in HER2..:

PUTTEMANS Janik ; DEKEMPENEER Yana ; EERSELS Jos...
JRC119863.  , 2020
Link: https://publications.jrc..
 
?
12

Two‐year safety and efficacy outcomes for the treatment of ..:

Blok, Bertil ; Van Kerrebroeck, Philip ; de Wachter, Stephan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217215/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
13

Development of a flowchart reflecting the current attitude ..:

Ghijselings, Lynn ; Hervé, Francois ; Van der Aa, Frank...
boreal:249935.  , 2020
Link: http://hdl.handle.net/20..
 
?
14

Tolerability and safety of urotainer® polihexanide 0.02% in..:

Pannek, Jürgen ; Everaert, Karel ; Möhr, Sandra...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346619/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
15

Efficacy and safety of artificial urinary sphincter (AUS): ..:

Tutolo, Manuela ; Cornu, Jean‐Nicolas ; Bauer, Ricarda M...
0733-2467.  , 2019
Link: https://resolver.sub.uni..
 
1-15